Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsector
Small molecules
Indications
Endocrine, nutritional and metabolic diseases / endocrinology
Cardiovascular / cardiology
Digestive system / gastroenterology
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 11
Description
Eccogene is a company focused on discovering and developing small molecule therapeutics for metabolic and immune-related diseases. The company's pipeline includes programs targeting GLP-1 receptor, thyroid hormone receptor beta (THRβ) and semicarbazide-sensitive amine oxidase (SSAO), as well as preclinical programs targeting the GIP receptor. The company's lead program, ECC5004 (AZD5004), is an oral small molecule GLP-1 receptor agonist licensed to AstraZeneca for development and commercialization...
